Capricor
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Capricor and other ETFs, options, and stocks.About CAPR
Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine.
CAPR Key Statistics
Stock Snapshot
With a market cap of 1.23B, Capricor(CAPR) trades at $26.79. The stock has a price-to-earnings ratio of -14.95.
As of 2025-12-07, Capricor(CAPR) stock has fluctuated between $26.00 and $28.63. The current price stands at $26.79, placing the stock +3.0% above today's low and -6.4% off the high.
Capricor(CAPR) shares are trading with a volume of 7.04M, against a daily average of 9.83M.
In the last year, Capricor(CAPR) shares hit a 52-week high of $40.37 and a 52-week low of $4.30.
In the last year, Capricor(CAPR) shares hit a 52-week high of $40.37 and a 52-week low of $4.30.
CAPR News
The average one-year price target for Capricor Therapeutics (NasdaqCM:CAPR) has been revised to $38.96 / share. This is an increase of 84.54% from the prior est...
TipRanks Cyber Monday Sale Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRank...
Capricor Therapeutics (CAPR) announced the commencement of a proposed underwritten public offering of shares of its common stock. The company intends to use the...
Analyst ratings
100%
of 10 ratingsMore CAPR News
Capricor Therapeutics, Inc. (NASDAQ:CAPR) stock soared on Wednesday after the company announced positive topline data from the Phase 3 HOPE-3 trial for its lead...